rs142235256

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006514.4(SCN10A):​c.1430C>T​(p.Pro477Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00075 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P477S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00079 ( 0 hom. )

Consequence

SCN10A
NM_006514.4 missense

Scores

4
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.712

Publications

4 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • Brugada syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03691721).
BP6
Variant 3-38755819-G-A is Benign according to our data. Variant chr3-38755819-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 240663.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 58 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.1430C>T p.Pro477Leu missense_variant Exon 11 of 28 ENST00000449082.3 NP_006505.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.1430C>T p.Pro477Leu missense_variant Exon 11 of 28 1 NM_006514.4 ENSP00000390600.2
SCN10AENST00000643924.1 linkc.1430C>T p.Pro477Leu missense_variant Exon 10 of 27 ENSP00000495595.1
SCN10AENST00000655275.1 linkc.1457C>T p.Pro486Leu missense_variant Exon 11 of 28 ENSP00000499510.1

Frequencies

GnomAD3 genomes
AF:
0.000381
AC:
58
AN:
152114
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000779
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000517
AC:
130
AN:
251480
AF XY:
0.000581
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000914
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000789
AC:
1153
AN:
1461712
Hom.:
0
Cov.:
31
AF XY:
0.000810
AC XY:
589
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33470
American (AMR)
AF:
0.000112
AC:
5
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000719
AC:
62
AN:
86236
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5648
European-Non Finnish (NFE)
AF:
0.000936
AC:
1041
AN:
1112000
Other (OTH)
AF:
0.000662
AC:
40
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000381
AC:
58
AN:
152232
Hom.:
0
Cov.:
32
AF XY:
0.000296
AC XY:
22
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41530
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000779
AC:
53
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000718
Hom.:
0
Bravo
AF:
0.000385
TwinsUK
AF:
0.000270
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000494
AC:
60
EpiCase
AF:
0.000654
EpiControl
AF:
0.000533

ClinVar

Significance: Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
Dec 03, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN10A c.1430C>T (p.Pro477Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00052 in 251480 control chromosomes, predominantly at a frequency of 0.00091 within the Non-Finnish European subpopulation in the gnomAD database. The allele frequency suggests that the variant is likely not associated with high a penetrance, severe, dominant disease phenotype. To our knowledge, no occurrence of c.1430C>T in individuals affected with Episodic pain syndrome, familial, 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 240663). Based on the evidence outlined above, the variant was classified as likely benign.

Episodic pain syndrome, familial, 2 Benign:1
Sep 13, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Brugada syndrome Benign:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Nov 25, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
8.0
DANN
Benign
0.60
DEOGEN2
Uncertain
0.47
T;.;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
LIST_S2
Benign
0.0
.;T;T;T
M_CAP
Benign
0.073
D
MetaRNN
Benign
0.037
T;T;T;T
MetaSVM
Uncertain
-0.19
T
MutationAssessor
Uncertain
2.2
M;.;M;.
PhyloP100
-0.71
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-3.3
D;.;.;.
Sift
Benign
0.074
T;.;.;.
Sift4G
Benign
0.45
T;.;.;.
Vest4
0.10
ClinPred
0.025
T
GERP RS
0.15
Varity_R
0.055
gMVP
0.23
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142235256; hg19: chr3-38797310; COSMIC: COSV101479591; API